加拿大魁北克省努纳维克因纽特人群的中耳炎相关中耳异常患病率与肺炎球菌疫苗接种的关系
本研究评估了努纳维克因纽特儿童5岁时中耳异常患病率与不同肺炎球菌结合疫苗接种程序的关系。在3517名有完整记录的儿童中,轻度异常患病率为29%,重度异常为18%;轻度异常频率在未接种儿童中较高(34%),在接种PCV7、PCV7+PCV10、PCV10和PCV10+PCV13的儿童中较低(分别为22%、17%、15%和18%),重度异常在各接种程序间无实质差异。结论认为肺炎球菌结合疫苗接种与中耳异常频率降低相关,但对重度异常未见效果,后者可能由早发性中耳炎触发。
要点
- 5岁时轻度中耳异常患病率为29%,重度异常为18%。
- 轻度异常频率在未接种儿童中为34%,接种PCV7、PCV7+PCV10、PCV10和PCV10+PCV13儿童分别为22%、17%、15%和18%。
- 重度异常在各疫苗接种程序间无实质差异。
核心结论
- 肺炎球菌结合疫苗接种与中耳异常频率降低相关,但对重度异常未见效果,后者可能由早发性中耳炎触发。
研究设计与样本
- 回顾性审查1994-2010年出生儿童在5岁时的免疫接种卡和听力筛查测试,根据推荐接种程序或实际接种疫苗分类,使用对数链接二项回归模型评估不同接种程序的相对异常风险。
- 共纳入3517名有完整记录的儿童。
主要发现
- 轻度中耳异常患病率为29%,重度异常患病率为18%。
- 轻度异常频率在未接种儿童中为34%,在接种PCV7、PCV7+PCV10、PCV10和PCV10+PCV13的儿童中分别为22%、17%、15%和18%。
- 重度异常在各疫苗接种程序间无实质差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Otitis media (OM) constitutes an important public health problem in the Inuit population of Nunavik, Northern Quebec. One of the objectives of the childhood pneumococcal vaccination program is to reduce OM burden. The program was implemented in 2002, and 7-, 10-, and 13-valent conjugate vaccines were used sequentially, with doses offered at 2, 4, 6 and 12-18 months, respectively. OBJECTIVE: To assess the prevalence of middle ear abnormalities at age 5 years in relation with exposure to different pneumococcal conjugate vaccines. METHODS: Immunization cards and audiology screening tests at age 5 years of children born in 1994-2010 were reviewed. Children were classified according to the vaccine schedule recommended for their birth cohort or to the vaccines they actually received. Log-linked binomial regression models were used to assess the relative abnormalities risk according to different vaccination schedules. RESULTS: Among 3517 children with complete documentation, the prevalences of minor and major abnormalities were 29% and 18%, respectively. Minor abnormalities frequency was higher in unvaccinated children (34%) and lower in children vaccinated with PCV7 (22%), PCV7 + PCV10 (17%), PCV10 (15%) and PCV10 + PCV13 (18%). No substantial differences among vaccine schedules were observed for major abnormalities. CONCLUSIONS: Pneumococcal conjugate vaccination was associated with a decreased frequency of middle ear abnormalities although no effect was seen for major abnormalities which may be trigger by OM with early onset. Clinicaltrials.gov registration number: NCT01694329.
引用
- Le Meur JB, Ayukawa H, Proulx JF, et al. Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada. Vaccine. 2018. PMID: 30026032. doi:10.1016/j.vaccine.2018.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。